Ligand Pharmaceuticals Inc (LGND)
110.14
+0.10
(+0.09%)
USD |
NASDAQ |
Nov 04, 13:15
Ligand Pharmaceuticals Total Assets (Quarterly): 866.40M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 866.40M |
| March 31, 2024 | 913.87M |
| December 31, 2023 | 787.22M |
| September 30, 2023 | 769.23M |
| June 30, 2023 | 758.10M |
| March 31, 2023 | 811.08M |
| December 31, 2022 | 762.67M |
| September 30, 2022 | 1.051B |
| June 30, 2022 | 1.076B |
| March 31, 2022 | 1.105B |
| December 31, 2021 | 1.298B |
| September 30, 2021 | 1.274B |
| June 30, 2021 | 1.256B |
| March 31, 2021 | 1.295B |
| December 31, 2020 | 1.362B |
| September 30, 2020 | 1.247B |
| June 30, 2020 | 1.243B |
| March 31, 2020 | 1.186B |
| December 31, 2019 | 1.495B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 1.802B |
| March 31, 2019 | 1.914B |
| December 31, 2018 | 1.261B |
| September 30, 2018 | 2.106B |
| June 30, 2018 | 1.858B |
| Date | Value |
|---|---|
| March 31, 2018 | 754.67M |
| December 31, 2017 | 671.02M |
| September 30, 2017 | 662.34M |
| June 30, 2017 | 640.02M |
| March 31, 2017 | 629.72M |
| December 31, 2016 | 601.58M |
| September 30, 2016 | 600.86M |
| June 30, 2016 | 616.80M |
| March 31, 2016 | 613.44M |
| December 31, 2015 | 503.06M |
| September 30, 2015 | 521.70M |
| June 30, 2015 | 304.76M |
| March 31, 2015 | 263.22M |
| December 31, 2014 | 258.03M |
| September 30, 2014 | 272.28M |
| June 30, 2014 | 99.85M |
| March 31, 2014 | 105.47M |
| December 31, 2013 | 104.71M |
| September 30, 2013 | 101.68M |
| June 30, 2013 | 99.57M |
| March 31, 2013 | 98.36M |
| December 31, 2012 | 104.26M |
| September 30, 2012 | 97.51M |
| June 30, 2012 | 104.59M |
| March 31, 2012 | 111.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
758.10M
Minimum
Jun 2023
1.495B
Maximum
Dec 2019
1.082B
Average
1.105B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 37.44B |
| Agios Pharmaceuticals Inc | 773.06M |
| ADMA Biologics Inc | 376.40M |
| Pieris Pharmaceuticals Inc | 25.05M |
| AnaptysBio Inc | 427.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.21M |
| Shareholders Equity (Quarterly) | 775.20M |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 1.01% |